STOCK TITAN

Rhythm Pharmaceuticals officer proposes $1.32M sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Rhythm Pharmaceuticals, Inc. (RYTM) common shares are the subject of Pamela Cramer’s proposed sale of 11,406 shares, with an aggregate market value of $1,317,164.88 and an approximate sale date of August 11, 2026. Pamela Cramer is identified as an officer.

Remarks state that the securities to be sold were acquired upon vesting of restricted stock units from July 26, 2022, through July 26, 2024. The notice gives December 15, 2025, as the plan adoption or instruction date under its Rule 10b5-1 entry.

Proposed sale 11,406 shares Common shares listed for sale
Aggregate market value $1,317,164.88 Proposed sale
Shares outstanding 68,852,082 shares Common shares outstanding listed in the securities information
Prior shares sold 3,520 shares Past-three-months table; sold August 10, 2026
Gross proceeds $411,452.80 Past-three-months sale on August 10, 2026
Shares acquired through stock-option exercise 5,257 shares Acquisition entry dated August 11, 2026
Restricted stock units 6,149 shares Acquisition entry dated July 26, 2022
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Restricted Stock Units financial
"Nature of Acquisition Transaction: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RYTM shares is Pamela Cramer proposing to sell?

Pamela Cramer is proposing to sell 11,406 common shares, with an aggregate market value of $1,317,164.88 and an approximate sale date of August 11, 2026.

How many shares did Pamela Cramer sell in the past three months?

The past-three-months sales table lists 3,520 shares sold on August 10, 2026, for gross proceeds of $411,452.80; the entry identifies them as 10b5-1 sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading